Araki R, Uda M, Hoki Y, Sunayama M, Nakamura M, Ando S, Sugiura M, Ideno H, Shimada A, Nifuji A, Abe M.

Nature. 2013 Jan 9. doi: 10.1038/nature11807.

Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells.

Differences between clones may be more crucial than differences between ES and iPS cells.